CPRIT Innovations VII: The Cancer Prevention and Research Conference

SwRI will be exhibiting at the CPRIT Innovations VII: The Cancer Prevention and Research Conference.

SwRI supports every phase of pharmaceutical development with an emphasis on current GMP manufacturing. From discovery to lead optimization and all the way through clinical trial supply services, SwRI provides extensive laboratory space including more than 20,000 square feet dedicated to advancing CGMP manufacturing projects. We deliver expertise to expand our client’s projects beyond academic research toward commercial viability.

SwRI also offers customized support for:

• Establishing funding routes (dilutive vs. non-dilutive)
• Navigating regulatory approval
• Adhering to Current Good Manufacturing Practices
• ISO certifications and audit-readiness best practices
• Program management and regulatory submissions
• Investigational new drug (IND) submission packages
• Chemistry, manufacturing, and controls (CMC) development
• Formulation and encapsulation technologies
• Bioanalytical method development and stability testing

Join us for the following poster sessions:

“Generative Approaches for Molecular Encodings for AI-Enabled Medicinal Chemistry Workflows” — SwRI Research Scientist Daniel Hinojosa

“AI-Guided Design of a Next-Generation CDK4-Selective Inhibitor for Desmoplastic Small Round Cell Tumor” — SwRI Lead Scientist Shawn Blumberg

For more information, please contact Daniel Hinojosa.